GlassScriptPhysician profile
Tarryn A Gardner
NPI 1467982447
$2,257.75
in general payments reported to CMS, 2019-2025
13 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $437 · 2022: $303 · 2023: $798 · 2024: $331 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $608.80 | 2021-2025 | Puraply, Affinity, Puraply Wound Matrix |
| Smith+Nephew, INC. | $547.87 | 2021-2024 | Oasis, Stravix, Grafix Pl |
| Hollister Incorporated | $270.35 | 2021-2025 | New Image, Premier, Adapt Ceraring |
| Kci USA, INC. | $188.09 | 2021-2023 | Activ.A.C., Kerramax Care, Promogran Prisma |
| Convatec INC. | $130.45 | 2022-2024 | |
| Medline Industries LP | $124.34 | 2021 | |
| Solventum Corporation | $107.24 | 2024-2025 | Activ.A.C., Promogran Prisma, Prevena |
| Tactile Systems Technology INC | $80.86 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Molnlycke Health Care US, LLC | $53.77 | 2023-2025 | Mepilex Transfer Ag, Mepitel Ag, Mepilex Border Flex |
| Hydrofera LLC | $47.51 | 2024-2025 | Hydrofera Blue |
| Abbvie INC. | $43.27 | 2021-2022 | |
| Coloplast Corp | $37.42 | 2024-2025 | |
| Kerecis Limited | $17.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarryn Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.